Bioprosthetics market expected to reach $14.5 billion by 2032, driven by technological innovations

From GlobeNewswire: 2025-02-28 08:05:00

The Bioprosthetics Market was valued at USD 5.8 Billion in 2023 and is projected to reach USD 14.5 Billion by 2032. Technological innovations and a rising prevalence of cardiovascular diseases are driving the market growth at a CAGR of 10.7% during the forecast period of 2024-2032.

Bioprosthetics, using biological materials for prosthetic devices, offer better biocompatibility and functionality than synthetic options. Technological advancements and minimally invasive surgical techniques have improved patient outcomes and expanded the target population for bioprosthetic implants.

Key companies in the bioprosthetics market include Medtronic, Abbott Laboratories, and Edwards Lifesciences Corporation. North America dominated the market in 2023, with a 38% revenue share, while the Asia-Pacific region is expected to see the highest growth due to increasing healthcare spending and patient population.

Recent developments in the market include LATTICE MEDICAL securing funding for its bioprosthesis project and Abbott receiving FDA approval for its tissue valve. Cardiovascular diseases remain a leading cause of mortality globally, emphasizing the need for bioprosthetic solutions to address heart diseases effectively. The Bioprosthetics Market report covers product analysis, application insights, regional breakdown, company profiles, use cases, and best practices. Access the complete report details for a comprehensive analysis and outlook for 2024-2032 at SNS Insider. Get current, accurate market data and consumer insights to make confident decisions in a changing market landscape.



Read more at GlobeNewswire: Bioprosthetics Market Size to Hit USD 14.5 Billion by 2032